학술논문

Relationship Between Canagliflozin, Sodium Glucose Cotransporter 2 Inhibitor, and Hematopoietic Effects in Patients With Diabetes and Mild Heart Failure: Results From the CANDLE Trial.
Document Type
Article
Source
Journal of Cardiovascular Pharmacology; Jul2023, Vol. 82 Issue 1, p61-68, 8p
Subject
Language
ISSN
01602446